Prophylactic treatment by periodic supplementation of deficient clotting factors is a method that has been applied for many years in developed countries, showing significant effectiveness compared to treatment in the presence of bleeding and has been recognized by the United Nations. The World Hemophilia Society recommends it as an essential treatment for patients.